APP and neuroblastoma: The diminution of Pdk4 observed in hAPP-expressing cells indicates that hAPP expression and/or increase in total APP content enhances glycolytic metabolism, as reported in human neuroblastoma cells in which increase in neuronal hAPP levels mediates an Aβ-independent Pdk4 downregulation (42).